Immunome Inc (IMNM)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Immunome Inc-Aktie (IMNM)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	73.11% 1.029	3.826	3.565	4.263	2.364
Operating Expenses	35.39% 133.33	98.48	8.198	10.04	6.835
Benefits Costs and Expenses	35.31% 130.52	96.46	-	-	6.634
Costs And Expenses	35.31% 130.52	96.46	8.198	10.04	6.634
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	39.77% -132.30	-94.65	-4.633	-5.773	-4.471
Net Interest Income/Expense	39.03% 2.807	2.019	0.288	0.216	0.201
Interest Income/Expense After Provision For Losses	39.03% 2.807	2.019	0.288	0.216	0.201
Income/Loss From Continuing Operations Before Tax	39.79% -129.49	-92.63	3.565	4.263	-4.27
Income/Loss From Continuing Operations After Tax	39.79% -129.49	-92.63	-4.345	-5.557	-4.27
Net Income/Loss	39.79% -129.49	-92.63	-4.345	-5.557	-4.27
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	573.84% 51.54	7.6494	12.20	12.20	12.18
Diluted Average Shares	573.84% 51.54	7.6494	12.20	12.20	12.18
Basic Earnings Per Share	40.52% -2.51	-4.22	-0.36	-0.46	-0.35
Diluted Earnings Per Share	40.52% -2.51	-4.22	-0.36	-0.46	-0.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$70.39

0.93%

SMMT

$18.42

1.07%

MRNA

$38.25

3.55%

UTHR

$367.36

0.83%

BGNE

$194.56

0.15%

BNTX

$108.23

5.96%